LC KILLS MORE PEOPLE THAN BREAST,
PROSTATE, COLON, LIVER, MELANOMA,
AND KIDNEY CANCERS COMBINED.

 

Cell Therapeutics, Inc. (CTI) Announces ASCO Activities

cell therap.jpgCell Therapeutics, Inc. (CTI) today announced presentations of interest on lung cancer and on its development candidate XYOTAX(TM) (paclitaxel poliglumex) at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting, being held June 1-5, 2007, in Chicago.

 

Trackback

 

Leave a Reply